
日本研究者发起的临床研究监管经验介绍及对我国的启示
The regulatory experience of investigator-initiated trials in Japan and its implications for China
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |